Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ysios Capital

Investor type Venture Capital
Founders Joel Jean Mairet

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 62
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 36
Rounds per year 4.43
Lead investments 15
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 10
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
Summary

Ysios Capital appeared to be the VC, which was created in 2008. The fund was located in Europe if to be more exact in Spain. The main department of described VC is located in the Barcelona.

The fund was created by Joel Jean Mairet. Besides them, we counted 6 critical employees of this fund in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Ysios Capital works on 6 percentage points less the average amount of lead investments. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Ysios Capital, startups are often financed by Kurma Partners, Caixa Capital Risc, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Life Sciences Partners, Idinvest Partners, Andera Partners. In the next rounds fund is usually obtained by Caixa Capital Risc, Kurma Partners, Gilde Healthcare.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Among the most popular fund investment industries, there are Medical, Hospital. Among the various public portfolio startups of the fund, we may underline CVRx, AM Pharma, BioVex The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.

Read more

Funds with similar focus

Funds from Spain
Funds with similar focus located in Spain:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aldrich Capital Partners Bethesda, Maryland, United States
Arm Accelerator Beijing, Beijing, China
Exponentially I Mobility India, Maharashtra, Mumbai
Inflection Ventures Central, Central Region, Singapore
InnoMed Capital -
Juhe Touzi Anhui, China, Hefei
Lakson Investments Venture Capital Karachi, Pakistan, Sindh
Navus Ventures Netherlands, South Holland, The Netherlands
Newton Press Japan, Tokyo
Polish Agency for Enterprise Development Mazowieckie, Poland, Warszawa
QNBEYOND Ventures -
Shri Investments -
SORITA PLUS -
Steel Dynamics Fort Wayne, Indiana, United States
Toyota Industries Corp Awaji, Hyogo Prefecture, Japan
U.S. Army Medical Research & Development Command Louisiana, Maryland, United States
Valid S.A Brazil, São Paulo, Sao Paulo
Wanrong Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mineralys Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$118M08 Jun 2022 Radnor, Pennsylvania, United States

Minoryx Therapeutics

Biotechnology
Genetics
Medical
Pharmaceutical
$60M31 May 2022 Barcelona, Catalonia, Spain

Splice Bio

Biotechnology
Life Science
Medical
Pharmaceutical
$59M15 Feb 2022 Barcelona, Catalonia, Spain

NorthSea Therapeutics

Biotechnology
Health Care
Therapeutics
$80M17 Dec 2021 The Netherlands, North Holland, Netherlands

Aura Biosciences

Biotechnology
Health Care
Pharmaceutical
03 Nov 2021 Cambridge, Massachusetts, United States

Aelix Therapeutics

Biotechnology
Health Care
Therapeutics
$2M16 Sep 2021 Barcelona, Catalonia, Spain

Biotechnology
Life Science
$45M04 May 2021 Denmark, Capital Region of Denmark, Denmark

ADCendo

Biotechnology
$60M29 Apr 2021 Copenhagen, Capital Region of Denmark, Denmark

Synendos Therapeutics

Health Care
Medical
Therapeutics
$26M20 Apr 2021 Basel-Country, Switzerland
News
Aura Biosciences Announces Oversubscribed $80 Million Financing

– Aura Biosciences closed an oversubscribed $80m financing.
– The financing was led by Matrix Capital Management and Surveyor Capital (a Citadel company) with participation from new investors, including Rock Springs Capital, Adage Capital Management LP and Velosity Capital.
– Existing investors Medicxi, Advent Life Sciences, Lundbeckfonden Ventures, Arix Bioscience, Chiesi Ventures, Ysios Capital and Columbus Venture Partners also participated in the round.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ysios Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: